Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Multiple Myeloma 10Leukemia, Myeloid, Acute 9Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Burkitt Lymphoma 8Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Lymphoma 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Lymphocytic, Chronic, B-Cell 7Myelodysplastic Syndromes 6Anemia, Refractory, with Excess of Blasts 6Hodgkin Disease 5Neoplasms, Plasma Cell 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Prolymphocytic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Leukemia 4Congenital Abnormalities 4Recurrence 3Primary Myelofibrosis 3Myeloproliferative Disorders 3Graft vs Host Disease 3Dendritic Cell Sarcoma, Interdigitating 3Breast Neoplasms 3Thrombocythemia, Essential 2

Interventions

pimodivir 1Sunitinib 1Rosuvastatin Calcium 1Midazolam 1Cyclosporine 1Adalimumab 1(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Healthy × Cyclosporine × Clear all
NCT03768609 2019-04-29

A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults

Janssen-Cilag International NV

Phase 1 Completed
18 enrolled

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡